Vir Biotechnology, Inc DEFA14A, filed Apr 7, 2022
Vir Biotechnology, Inc. (VIR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
Vir Biotechnology, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Your Vote Counts!
VIR BIOTECHNOLOGY, INC.
2022 Annual Meeting
Vote by May 19, 2022 11:59 PM ET
VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO, CA 94158
D78516-P70230
You invested in VIR BIOTECHNOLOGY, INC. and it’s time to vote!
You have
the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on May 20, 2022.
Get informed before you vote
View the Notice and Proxy Statement and Annual Report online OR
you can receive a free paper or email copy of the material(s) by requesting prior to May 8, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com,
(2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your
control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
For complete information and to vote,
visit www.ProxyVote.com Control #
Smartphone users Vote Virtually at the Meeting*
Point your camera here and May 20, 2022.
11:30 AM PT
vote without entering a control number
Virtually at: www.virtualshareholdermeeting.com/VIR2022
*Please check the meeting materials
for any special requirements for meeting attendance.
V1.1
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE
BALLOT
This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these
important matters.
Voting Items Board Recommends
1. To elect the following
three nominees for director to hold office until the 2025 Annual Meeting of Stockholders
Nominees:
1a. Jeffrey S. Hatfield For 1b. Saira Ramasastry For 1c. George Scangos, Ph.D. For
2. To
approve, on an advisory basis, the compensation of the Company’s named executive officers. For
3. To ratify the selection by the Audit Committee of the Board
of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. For NOTE: Such other business as may properly come before the meeting or any
adjournment thereof.
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for
E-delivery”.
D78517-P70230